The 2024–25 U.S. influenza season is underway and now is the time to vaccinate. For week 45, ending November 9, CDC’s Weekly U.S. Influenza Surveillance Report, FluView, shows influenza activity increasing slightly among children and involving more states.



RESP-NET
Visit the CDC Respiratory Virus Hospitalization Surveillance Network (RESP-NET) for weekly reports of hospitalizations due to three vaccine-preventable seasonal respiratory viruses: COVID-19, influenza, and RSV. 

Influenza Vaccination Dashboard
CDC's Weekly Flu Vaccination Dashboard shows that, as of November 2, 2024, 30.5% of U.S. children received flu vaccination, lower than last season at this time. The percentage of children who received flu vaccination varies dramatically from state to state, from a low of just 4.2% to a high of 54.9%.

 
CDC reports that, nationally, adult vaccination as of November 2, 2024, was 32,1%, similar to last year at this point. State-by-state coverage rates among adults also vary widely, from a low of 18.5% to a high of 59.3%.

CDC recommends everyone age 6 months and older get annual influenza vaccination. Influenza and other vaccines (e.g., COVID-19, RSV) may be given at the same visit, if needed. Infants age 6 months and older may receive influenza and COVID-19 vaccines at the same visit when they receive the RSV preventive antibody, nirsevimab [Beyfortus, Sanofi].

Identify pharmacies in your area that may offer influenza and COVID-19 vaccines by entering a zip code in the VaccineFinder on Vaccines.gov or Vacunas.gov.

Related Links

• CDC: Weekly National Flu Vaccination Dashboard main page
• CDC: FluView main page
• CDC: RESP-NET main page
• Immunize​.org: free clinical resources and patient handouts related to influenza
• Immunize​.org: Vaccines A–Z: Influenza main page
• Immunize​.org: Ask the Experts: Influenza main page

Back to top

Do you ever need to locate vaccine-related communications or announcements from ACIP, CDC, or FDA? Immunize​.org gathers them in our Official Release Repository web page within the "News & Updates" menu atop each page.  
 
The Official Release Repository contains a searchable list of announcements from ACIP, CDC, and FDA dating back to 2015. Each document source (ACIP, CDC, FDA) is available from its own tab. Within the category, we include filters allowing you to narrow your search by publication year, vaccine or disease type, or patient age group.
 
To access the repository:  

• Click on the “News & Updates” tab on the menu bar found atop each page.  
• Select “Official Release Repository” on the left menu.  
• Select the “ACIP,” “CDC,” or “FDA” tab.  
• Filters you choose will indicate the number of available results. Click on the dropdown list to add a filter. Remove a filter by clicking “x” within the blue filter rectangle. 

 

Back to top

 

---

Recap: Immunize​.org updates “Measles: Questions and Answers”

Immunize​.org updated its resource Measles: Questions and Answers. Updates revise rates of measles complications, data on current outbreaks, and several URLs.



Related Links

• Immunize​.org: Vaccines A–Z: Measles main page
• Immunize​.org: Clinical Resources A–Z main page, where you can filter by topic, vaccine, language, or other criteria

Back to top

Do you need to know the year that CDC made a vaccination recommendation or FDA approved a new vaccine? Refer to Immunize​.org’s Vaccine History Timeline. This useful reference was recently updated to include new vaccine-related events.



If you would like to suggest an event to add, contact us at [email protected].

The American Pharmacists Association's (APhA) Vaccine Confident website offers educational webinars, podcasts, patient resources, and video success stories to build vaccine confidence. The website links to the Conversation Guide web page, which offers suggestions on multiple communication themes or audience segments. The Vaccine Confident collection is an action-oriented resource to guide and enhance pharmacist-patient conversations regarding vaccines. 

The website also offers two interactive vaccine access maps to identify pharmacy vaccination locations and healthcare provider locations.



Visit APhA's Vaccine Confident website.

For its January 1, 2025 issue, Vaccine published Multisystem Inflammatory Syndrome in Children (MIS-C) Cases by Vaccination Status in California. The abstract appears below.

Multisystem inflammatory syndrome in children (MIS-C) is a rare condition occurring after SARS-CoV-2 infection in children under 21 years of age. Children (5–17 years) with MIS-C meeting the Centers for Disease Control (CDC) case definition were reported via California's passive disease surveillance system. Incidence of MIS-C was compared in unvaccinated and Pfizer-BioNTech vaccinated children aged 12–17 and 5–11 years. . . . Compared with vaccinated children, the incident rate ratio of MIS-C was higher among unvaccinated children in both the 12–17-year-old group (22.9, 95% confidence interval [CI]: 10.5–49.8, p < 0.0001) and the 5–11-year-old group (3.3, 95% CI: 1.6–6.7, p = 0.0004). While MIS-C is rare, our results suggest that vaccination with the Pfizer-BioNTech vaccine is protective against MIS-C.